Nisa Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.5M Sell
120,878
-8,986
-7% -$4.88M 0.22% 53
2025
Q4
$75.3M Buy
129,864
+3,612
+3% +$2.04M 0.25% 45
2025
Q3
$61.3M Sell
126,252
-2,012
-2% -$937K 0.24% 55
2025
Q2
$52.1M Sell
128,264
-8,669
-6% -$3.62M 0.23% 65
2025
Q1
$68.2M Sell
136,933
-10,488
-7% -$5.68M 0.34% 43
2024
Q4
$76.7M Buy
147,421
+6,713
+5% +$3.69M 0.3% 42
2024
Q3
$87.1M Buy
140,708
+8,180
+6% +$4.84M 0.52% 29
2024
Q2
$73.3M Sell
132,528
-15,306
-10% -$8.77M 0.46% 34
2024
Q1
$86M Buy
147,834
+18,333
+14% +$10.3M 0.56% 26
2023
Q4
$68.7M Buy
129,501
+676
+0.5% +$327K 0.49% 35
2023
Q3
$65.2M Sell
128,825
-4,429
-3% -$2.36M 0.5% 34
2023
Q2
$69.5M Buy
133,254
+922
+0.7% +$498K 0.51% 32
2023
Q1
$76.3M Sell
132,332
-55
-0% -$31K 0.6% 26
2022
Q4
$72.9M Sell
132,387
-3,492
-3% -$1.85M 0.58% 23
2022
Q3
$68.9M Sell
135,879
-1,521
-1% -$851K 0.59% 24
2022
Q2
$74.6M Buy
137,400
+5,560
+4% +$3.06M 0.65% 20
2022
Q1
$77.9M Sell
131,840
-2,767
-2% -$1.59M 0.55% 29
2021
Q4
$78.2M Buy
134,607
+2,514
+2% +$1.57M 0.59% 29
2021
Q3
$75.5K Sell
132,093
-1,325
-1% -$727K 0.46% 35
2021
Q2
$67.3K Sell
133,418
-13,010
-9% -$6.14M 0.42% 41
2021
Q1
$66.8K Sell
146,428
-5,756
-4% -$2.75M 0.42% 41
2020
Q4
$70.9M Buy
152,184
+4,111
+3% +$1.93M 0.46% 42
2020
Q3
$65.4M Sell
148,073
-200
-0.1% -$82.6K 0.53% 39
2020
Q2
$53.7M Buy
148,273
+50
+0% +$16.8K 0.49% 42
2020
Q1
$42M Sell
148,223
-500
-0.3% -$158K 0.47% 46
2019
Q4
$48.3M Sell
148,723
-6,974
-4% -$2.11M 0.41% 48
2019
Q3
$45.4M Sell
155,697
-5,950
-4% -$1.7M 0.4% 46
2019
Q2
$47.5M Sell
161,647
-2,375
-1% -$654K 0.45% 45
2019
Q1
$44.9M Buy
164,022
+4,000
+2% +$995K 0.44% 50
2018
Q4
$35.8M Buy
160,022
+6,000
+4% +$1.41M 0.4% 55
2018
Q3
$37.6M Sell
154,022
-705
-0.5% -$162K 0.34% 61
2018
Q2
$32M Sell
154,727
-285
-0.2% -$60.5K 0.33% 68
2018
Q1
$32.1M Sell
155,012
-3,800
-2% -$798K 0.34% 67
2017
Q4
$30.2M Buy
158,812
+800
+0.5% +$153K 0.31% 75
2017
Q3
$29.9M Buy
158,012
+13,390
+9% +$2.42M 0.34% 64
2017
Q2
$25.2M Sell
144,622
-1,001
-0.7% -$168K 0.3% 74
2017
Q1
$22.4M Sell
145,623
-3,360
-2% -$514K 0.27% 84
2016
Q4
$21M Sell
148,983
-1,150
-0.8% -$170K 0.26% 82
2016
Q3
$23.9M Sell
150,133
-50
-0% -$7.71K 0.31% 67
2016
Q2
$22.2M Buy
150,183
+6,550
+5% +$967K 0.3% 74
2016
Q1
$20.3M Buy
143,633
+5,000
+4% +$670K 0.29% 74
2015
Q4
$19.7M Sell
138,633
-700
-0.5% -$93.4K 0.28% 80
2015
Q3
$17.1M Sell
139,333
-700
-0.5% -$91.2K 0.26% 90
2015
Q2
$18.2M Sell
140,033
-4,100
-3% -$535K 0.26% 91
2015
Q1
$19.4M Sell
144,133
-1,200
-0.8% -$155K 0.27% 88
2014
Q4
$18.2M Sell
145,333
-20,350
-12% -$2.47M 0.25% 89
2014
Q3
$20.2M Buy
165,683
+18,410
+13% +$2.24M 0.28% 82
2014
Q2
$17.4M Sell
147,273
-6,300
-4% -$741K 0.24% 95
2014
Q1
$18.5M Buy
153,573
+100
+0.1% +$11.9K 0.26% 86
2013
Q4
$17.1M Sell
153,473
-2,400
-2% -$239K 0.24% 90
2013
Q3
$14.4M Sell
155,873
-1,900
-1% -$172K 0.22% 99
2013
Q2
$13.4M Buy
+157,773
New +$13.1M 0.21% 106

Other funds holding TMO

Nisa Investment Advisors's TMO Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 6.9% in Q1 2026, selling an estimated $4.88M and leaving 120,878 shares worth $59.5M. The position accounts for 0.22% of the portfolio, ranked #53.

Nisa Investment Advisors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $87.1M in Q3 2024. 2,594 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Nisa Investment Advisors held 120,878 shares of Thermo Fisher Scientific worth $59.5M as of Q1 2026.
  • Nisa Investment Advisors sold 8,986 Thermo Fisher Scientific shares in Q1 2026, an estimated $4.88M.
  • Thermo Fisher Scientific made up 0.22% of Nisa Investment Advisors's portfolio in Q1 2026, its #53 holding.
  • Nisa Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Nisa Investment Advisors's Thermo Fisher Scientific position peaked at $87.1M in Q3 2024.
  • 2,594 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.